National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Central Nervous System Biomarkers Market Size, Status and Forecast 2019-2025

Global Central Nervous System Biomarkers Market Size, Status and Forecast 2019-2025

Goods_sn:dinghonglei-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Central Nervous System Biomarkers Market Size, Status and Forecast 2019-2025

Hard Copy: 3900 USD
PDF Copy (single user): 3900 USD
Multi User License: 5850 USD
Enterprise wide License: 7800 USD
Pages: 97
Tables and Figures: 104
Published Date: Oct. 2019
Publisher: QYR Medical Care Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological conditions.
In 2018, the global Central Nervous System Biomarkers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Central Nervous System Biomarkers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Central Nervous System Biomarkers development in United States, Europe and China.

The key players covered in this study
    Merck
    Takeda Pharmaceutical
    Thermo Fisher Scientific
    Avacta Group
    Diagenic Asa
    Banyan Biomarkers
    Eli Lilly
    Pfizer
    Alseres Pharmaceuticals
    Acumen pharmaceuticals
    EKF Diagnostics
    Abiant
    Myriad RBM
    Aposense

Market segment by Type, the product can be split into
    Safety Biomarker
    Efficacy Biomarker
    Validation Biomarker
    Other

Market segment by Application, split into
    Hospitals
    Clinics
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Central Nervous System Biomarkers status, future forecast, growth opportunity, key market and key players.
    To present the Central Nervous System Biomarkers development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Central Nervous System Biomarkers are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Central Nervous System Biomarkers Market Size Growth Rate by Type (2014-2025)
        1.4.2 Safety Biomarker
        1.4.3 Efficacy Biomarker
        1.4.4 Validation Biomarker
        1.4.5 Other
    1.5 Market by Application
        1.5.1 Global Central Nervous System Biomarkers Market Share by Application (2014-2025)
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Central Nervous System Biomarkers Market Size
    2.2 Central Nervous System Biomarkers Growth Trends by Regions
        2.2.1 Central Nervous System Biomarkers Market Size by Regions (2014-2025)
        2.2.2 Central Nervous System Biomarkers Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Central Nervous System Biomarkers Market Size by Manufacturers
        3.1.1 Global Central Nervous System Biomarkers Revenue by Manufacturers (2014-2019)
        3.1.2 Global Central Nervous System Biomarkers Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Central Nervous System Biomarkers Market Concentration Ratio (CR5 and HHI)
    3.2 Central Nervous System Biomarkers Key Players Head office and Area Served
    3.3 Key Players Central Nervous System Biomarkers Product/Solution/Service
    3.4 Date of Enter into Central Nervous System Biomarkers Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Central Nervous System Biomarkers Market Size by Type (2014-2019)
    4.2 Global Central Nervous System Biomarkers Market Size by Application (2014-2019)

5 United States
    5.1 United States Central Nervous System Biomarkers Market Size (2014-2019)
    5.2 Central Nervous System Biomarkers Key Players in United States
    5.3 United States Central Nervous System Biomarkers Market Size by Type
    5.4 United States Central Nervous System Biomarkers Market Size by Application

6 Europe
    6.1 Europe Central Nervous System Biomarkers Market Size (2014-2019)
    6.2 Central Nervous System Biomarkers Key Players in Europe
    6.3 Europe Central Nervous System Biomarkers Market Size by Type
    6.4 Europe Central Nervous System Biomarkers Market Size by Application

7 China
    7.1 China Central Nervous System Biomarkers Market Size (2014-2019)
    7.2 Central Nervous System Biomarkers Key Players in China
    7.3 China Central Nervous System Biomarkers Market Size by Type
    7.4 China Central Nervous System Biomarkers Market Size by Application

8 Japan
    8.1 Japan Central Nervous System Biomarkers Market Size (2014-2019)
    8.2 Central Nervous System Biomarkers Key Players in Japan
    8.3 Japan Central Nervous System Biomarkers Market Size by Type
    8.4 Japan Central Nervous System Biomarkers Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Central Nervous System Biomarkers Market Size (2014-2019)
    9.2 Central Nervous System Biomarkers Key Players in Southeast Asia
    9.3 Southeast Asia Central Nervous System Biomarkers Market Size by Type
    9.4 Southeast Asia Central Nervous System Biomarkers Market Size by Application

10 India
    10.1 India Central Nervous System Biomarkers Market Size (2014-2019)
    10.2 Central Nervous System Biomarkers Key Players in India
    10.3 India Central Nervous System Biomarkers Market Size by Type
    10.4 India Central Nervous System Biomarkers Market Size by Application

11 Central & South America
    11.1 Central & South America Central Nervous System Biomarkers Market Size (2014-2019)
    11.2 Central Nervous System Biomarkers Key Players in Central & South America
    11.3 Central & South America Central Nervous System Biomarkers Market Size by Type
    11.4 Central & South America Central Nervous System Biomarkers Market Size by Application

12 International Players Profiles
    12.1 Merck
        12.1.1 Merck Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Central Nervous System Biomarkers Introduction
        12.1.4 Merck Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.1.5 Merck Recent Development
    12.2 Takeda Pharmaceutical
        12.2.1 Takeda Pharmaceutical Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Central Nervous System Biomarkers Introduction
        12.2.4 Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.2.5 Takeda Pharmaceutical Recent Development
    12.3 Thermo Fisher Scientific
        12.3.1 Thermo Fisher Scientific Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Central Nervous System Biomarkers Introduction
        12.3.4 Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.3.5 Thermo Fisher Scientific Recent Development
    12.4 Avacta Group
        12.4.1 Avacta Group Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Central Nervous System Biomarkers Introduction
        12.4.4 Avacta Group Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.4.5 Avacta Group Recent Development
    12.5 Diagenic Asa
        12.5.1 Diagenic Asa Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Central Nervous System Biomarkers Introduction
        12.5.4 Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.5.5 Diagenic Asa Recent Development
    12.6 Banyan Biomarkers
        12.6.1 Banyan Biomarkers Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Central Nervous System Biomarkers Introduction
        12.6.4 Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.6.5 Banyan Biomarkers Recent Development
    12.7 Eli Lilly
        12.7.1 Eli Lilly Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Central Nervous System Biomarkers Introduction
        12.7.4 Eli Lilly Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.7.5 Eli Lilly Recent Development
    12.8 Pfizer
        12.8.1 Pfizer Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Central Nervous System Biomarkers Introduction
        12.8.4 Pfizer Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.8.5 Pfizer Recent Development
    12.9 Alseres Pharmaceuticals
        12.9.1 Alseres Pharmaceuticals Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Central Nervous System Biomarkers Introduction
        12.9.4 Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.9.5 Alseres Pharmaceuticals Recent Development
    12.10 Acumen pharmaceuticals
        12.10.1 Acumen pharmaceuticals Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Central Nervous System Biomarkers Introduction
        12.10.4 Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2014-2019)
        12.10.5 Acumen pharmaceuticals Recent Development
    12.11 EKF Diagnostics
    12.12 Abiant
    12.13 Myriad RBM
    12.14 Aposense

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details


List of Tables and Figures

    Table Central Nervous System Biomarkers Key Market Segments
    Table Key Players Central Nervous System Biomarkers Covered
    Table Global Central Nervous System Biomarkers Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Central Nervous System Biomarkers Market Size Market Share by Type 2014-2025
    Figure Safety Biomarker Figures
    Table Key Players of Safety Biomarker
    Figure Efficacy Biomarker Figures
    Table Key Players of Efficacy Biomarker
    Figure Validation Biomarker Figures
    Table Key Players of Validation Biomarker
    Figure Other Figures
    Table Key Players of Other
    Table Global Central Nervous System Biomarkers Market Size Growth by Application 2014-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Clinics Case Studies
    Figure Others Case Studies
    Figure Central Nervous System Biomarkers Report Years Considered
    Table Global Central Nervous System Biomarkers Market Size 2014-2025 (Million US$)
    Figure Global Central Nervous System Biomarkers Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Central Nervous System Biomarkers Market Size by Regions 2014-2025 (Million US$)
    Table Global Central Nervous System Biomarkers Market Size by Regions 2014-2019 (Million US$)
    Table Global Central Nervous System Biomarkers Market Share by Regions 2014-2019
    Figure Global Central Nervous System Biomarkers Market Share by Regions 2014-2019
    Figure Global Central Nervous System Biomarkers Market Share by Regions 2019
    Table Market Top Trends
    Table Global Central Nervous System Biomarkers Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Central Nervous System Biomarkers Market Share by Manufacturers (2014-2019)
    Figure Global Central Nervous System Biomarkers Market Share by Manufacturers in 2019
    Table Global Central Nervous System Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Central Nervous System Biomarkers Product/Solution/Service
    Table Date of Enter into Central Nervous System Biomarkers Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table Global Central Nervous System Biomarkers Market Size Share by Type (2014-2019)
    Figure Global Central Nervous System Biomarkers Market Size Market Share by Type (2014-2019)
    Table Global Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table Global Central Nervous System Biomarkers Market Size Share by Application (2014-2019)
    Figure Global Central Nervous System Biomarkers Market Size Market Share by Application (2014-2019)
    Figure Global Central Nervous System Biomarkers Revenue Market Share by Application in 2018
    Figure United States Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table United States Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
    Table United States Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table United States Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table United States Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table United States Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table United States Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Figure Europe Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table Europe Key Players Central Nervous System Biomarkers Revenue (2014-2019) (Million US$)
    Table Europe Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table Europe Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table Europe Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table Europe Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table Europe Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Figure China Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table China Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
    Table China Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table China Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table China Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table China Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table China Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Figure Japan Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table Japan Key Players Central Nervous System Biomarkers Revenue (2014-2019) (Million US$)
    Table Japan Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table Japan Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table Japan Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table Japan Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table Japan Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Figure Southeast Asia Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table Southeast Asia Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table Southeast Asia Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Figure India Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table India Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
    Table India Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table India Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table India Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table India Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table India Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Figure Central & South America Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Central Nervous System Biomarkers Market Share (2018-2019)
    Table Central & South America Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Central Nervous System Biomarkers Market Share by Type (2014-2019)
    Table Central & South America Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Central Nervous System Biomarkers Market Share by Application (2014-2019)
    Table Merck Company Details
    Table Merck Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Merck Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Merck Recent Development
    Table Takeda Pharmaceutical Company Details
    Table Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Takeda Pharmaceutical Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Takeda Pharmaceutical Recent Development
    Table Thermo Fisher Scientific Company Details
    Table Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Thermo Fisher Scientific Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Thermo Fisher Scientific Recent Development
    Table Avacta Group Company Details
    Table Avacta Group Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Avacta Group Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Avacta Group Recent Development
    Table Diagenic Asa Company Details
    Table Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Diagenic Asa Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Diagenic Asa Recent Development
    Table Banyan Biomarkers Company Details
    Table Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Banyan Biomarkers Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Banyan Biomarkers Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Eli Lilly Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Eli Lilly Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Pfizer Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Pfizer Recent Development
    Table Alseres Pharmaceuticals Company Details
    Table Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Alseres Pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Alseres Pharmaceuticals Recent Development
    Table Acumen pharmaceuticals Company Details
    Table Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2014-2019) (Million US$)
    Figure Acumen pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
    Table Acumen pharmaceuticals Recent Development
    Table EKF Diagnostics Company Details
    Table Abiant Company Details
    Table Myriad RBM Company Details
    Table Aposense Company Details
    Table Global Central Nervous System Biomarkers Market Size by Regions (Million US$) 2019-2025
    Figure Global Central Nervous System Biomarkers Market Size Share by Regions (2019-2025)
    Figure Global Central Nervous System Biomarkers Market Size Share by Regions in 2025
    Figure United States Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Figure China Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Figure India Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
    Table Global Central Nervous System Biomarkers Market Size by Product (2019-2025) (Million US$)
    Figure Global Central Nervous System Biomarkers Market Size by Product (2019-2025)
    Figure Global Central Nervous System Biomarkers Market Size by Product in 2025
    Table Global Central Nervous System Biomarkers Market Size by Application (2019-2025) (Million US$)
    Figure Global Central Nervous System Biomarkers Market Size by Application (2019-2025)
    Figure Global Central Nervous System Biomarkers Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.